{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Microbix &amp; Copan Italia Execute Strategic Agreement - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"C3J2shy2d9\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbix-copan-italia-execute-strategic-agreement\/\">Microbix &amp; Copan Italia Execute Strategic Agreement<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbix-copan-italia-execute-strategic-agreement\/embed\/#?secret=C3J2shy2d9\" width=\"600\" height=\"338\" title=\"&#8220;Microbix &amp; Copan Italia Execute Strategic Agreement&#8221; &#8212; Market Newsdesk\" data-secret=\"C3J2shy2d9\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"For FLOQ devices &amp; QAPs Co-branding, IP licensing, Co-marketing, Purchase and Supply MISSISSAUGA, Ontario and BRESCIA, Italy, Dec. 21, 2020 (GLOBE NEWSWIRE) &#8212; Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix\u00ae), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan\u00ae), the global leader in specimen collection technologies, announce their execution of a strategic agreement (Agreement) in relation to Microbix\u2019s quality assessment products (QAPs\u2122) and Copan\u2019s flocked devices (FLOQ\u00ae). The Agreement between Microbix and Copan expands upon an existing purchase and supply contract, adding licensing of Copan\u2019s issued patents for use of flocked devices to format test controls (broadly known as QAPs). Also, it formalizes the parties\u2019 agreement for joint usage of their respective brands for marketing of novel &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNTA2OSMzODg5MzExIzIwOTM5MDQ="}